Incidence of hyperkalemia in high risk patients during treatment with an angiotensin converting enzyme inhibitor (Lisinopril) versus an angiotensin II receptor blocker (Losartan).
Hyperkalemia is a known side effect during treatment with Angiotensin Converting Enzyme Inhibitors (ACEIs). The purpose of this study was to compare the effect of an ACEI (Lisinopril) to an Angiotensin II Receptor Blocker (Losartan) on serum potassium (K) level in patients with known history of high normal serum K (mean = 4.8) while on treatment with ACEIs or Angiotensin II Receptor Blockers (ARBs).
Zanabli
Abdul Rahman
AR
USD School of Medicine, Sioux Falls, SD, USA.
Yango
Angellito
A
Dworkin
Lance
L
D000328:Adult; D000368:Aged; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D018592:Cross-Over Studies; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D007676:Kidney Failure, Chronic / Q000150:complications; D017706:Lisinopril / Q000009:adverse effects*; D019808:Losartan / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D017706:Lisinopril; D019808:Losartan